Brief: Xbrane Biopharma Q2 EBITDA SEK -3.6 Mln

Xbrane Biopharma AB

26/08/2025 07:09

Aug 26 (Reuters) - Xbrane Biopharma AB XBRANE.ST:

XBRANE BIOPHARMA Q2 EPS SEK 0.11

XBRANE BIOPHARMA Q2 EBITDA SEK -3.6 MILLION

XBRANE BIOPHARMA Q2 NET INCOME SEK 169.6 MILLION

XBRANE BIOPHARMA Q2 REVENUE SEK 39.9 MILLION

Q2 2025 REVENUE AT SEK 39.9 MILLION

Q2 2025 EBITDA AT SEK -3.6 MILLION

Q2 2025 PROFIT AT SEK 169.6 MILLION

Q2 2025 EPS AT SEK 0.11

Source text: ID:nMFN8kvk5W

Further company coverage: XBRANE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))